Skip to main content
OpenTrials

Clinical trial condition

Acute Lymphoblastic Leukemia

Explore clinical trials studying Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

471 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia trial results

Completed

Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01256398

Conditions
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Hematologic Diseases, +10 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Rocky Mountain Cancer Centers-Boulder Boulder, Colorado, United States
View all 101 locations
View Trial Details
Completed

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

NCT02185781

Conditions
Acute Lymphoblastic Leukemia, Complete Hematologic Remission (CHR), Hematologic Diseases, +15 more
Locations
  • ISS/AIFA Roma, Italy
  • Ospedale S. Eugenio Roma, Italy
  • Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy
  • Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy
View Trial Details
Completed

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

NCT02743351

Conditions
Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +35 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California, San Diego (UCSD) Moores Cancer Center San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT03476239

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Chinese People Liberation Army General Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 23 locations
View Trial Details

Related conditions